| 1 |
Unger P, Tribouilloy C. Aortic stenosis with other concomitant valvular disease: aortic regurgitation, mitral regurgitation, mitral stenosis, or tricuspid regurgitation [J]. Cardiol Clin, 2020, 38(1): 33-46.
|
| 2 |
Tribouilloy C, Bohbot Y, Kubala M, et al. Characteristics, management, and outcomes of patients with multiple native valvular heart disease: a substudy of the EURObservational Research Programme Valvular Heart Disease II Survey [J]. Eur Heart J, 2022, 43(29): 2756-2766.
|
| 3 |
Andell P, Li X, Martinsson A, et al. Epidemiology of valvular heart disease in a Swedish nationwide hospital-based register study [J]. Heart, 2017, 103(21): 1696-1703.
|
| 4 |
Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease [J]. Eur Heart J, 2003, 24(13): 1231-1243.
|
| 5 |
Baumgartner H, Hung J, Bermejo J, et al. Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography [J]. J Am Soc Echocardiogr, 2017, 30(4): 372-392.
|
| 6 |
Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation [J]. Circulation, 2005, 111(7): 920-925.
|
| 7 |
Martinsson A, Li X, Andersson C, et al. Temporal trends in the incidence and prognosis of aortic stenosis: a nationwide study of the Swedish population [J]. Circulation, 2015, 131(11): 988-994.
|
| 8 |
Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease [J]. Eur Heart J, 2022, 43(7): 561-632.
|
| 9 |
Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) [J]. Eur J Cardiothorac Surg, 2012, 42(4): S1-S44.
|
| 10 |
Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines [J]. J Am Coll Cardiol, 2017, 70(2): 252-289.
|
| 11 |
Asami M, Windecker S, Praz F, et al. Transcatheter aortic valve replacement in patients with concomitant mitral stenosis [J]. Eur Heart J, 2019, 40(17): 1342-1351.
|
| 12 |
Ngiam JN, Chew NWS, Pramotedham T, et al. Implications of coexisting aortic regurgitation in patients with aortic stenosis [J]. JACC Asia, 2021, 1(1): 105-111.
|
| 13 |
Von Stumm M, Petersen J, Westermann D, et al. Treatment strategies for mixed aortic valve disease in nonelderly patients [J]. Expert Rev Cardiovasc Ther, 2019, 17(12): 873-882.
|
| 14 |
Ong G, Pibarot P. Combined aortic stenosis and regurgitation: double the trouble [J]. Heart, 2019, 105(19): 1515-1522.
|
| 15 |
Unger P, Pibarot P, Tribouilloy C, et al. Multiple and mixed valvular heart diseases [J]. Circ Cardiovasc Imaging, 2018, 11(8): e007862.
|
| 16 |
Unger P, Clavel M. Mixed aortic valve disease: a diagnostic challenge, a prognostic threat[J]. Struct Heart, 2020, 4(6): 468-474.
|
| 17 |
Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease [J]. Eur Heart J, 2017, 38(36): 2739-2791.
|
| 18 |
Gamaza-Chulián S, Díaz-Retamino E, Camacho-Freire S, et al. Acceleration time and ratio of acceleration time to ejection time in aortic stenosis: new echocardiographic diagnostic parameters [J]. J Am Soc Echocardiogr, 2017, 30(10): 947-955.
|
| 19 |
Marechaux S, Tribouilloy C. Acceleration time in aortic stenosis: a new life for an old parameter [J]. Circ Cardiovasc Imaging, 2021, 14(1): e012234.
|
| 20 |
Unger P, Powers A, Le Nezet E, et al. Prevalence and outcomes of patients with discordant high-gradient aortic stenosis [J]. J Am Coll Cardiol, 2024, 83(12): 1109-1119.
|
| 21 |
White M, Baral R, Ryding A, et al. Biomarkers associated with mortality in aortic stenosis: a systematic review and meta-analysis [J]. Med Sci (Basel), 2021, 9(2): 29.
|
| 22 |
Brener SJ, Duffy CI, Thomas JD, et al. Progression of aortic stenosis in 394 patients: relation to changes in myocardial and mitral valve dysfunction [J]. J Am Coll Cardiol, 1995, 25(2): 305-310.
|
| 23 |
Mantovani F, Barbieri A, Albini A, et al. The common combination of aortic stenosis with mitral regurgitation: diagnostic insight and therapeutic implications in the modern era of advanced echocardiography and percutaneous intervention [J]. J Clin Med, 2021, 10(19): 4364.
|
| 24 |
Unger P, Dedobbeleer C, Van Camp G, et al. Mitral regurgitation in patients with aortic stenosis undergoing valve replacement [J]. Heart, 2010, 96(1): 9-14.
|
| 25 |
Lee PH, Hong JA, Sun BJ, et al. Impact of significant mitral regurgitation on assessing the severity of aortic stenosis [J]. J Am Soc Echocardiogr, 2018, 31(1): 26-33.
|
| 26 |
Katte F, Franz M, Jung C, et al. Impact of concomitant mitral regurgitation on transvalvular gradient and flow in severe aortic stenosis: a systematic ex vivo analysis of a subentity of low-flow low-gradient aortic stenosis [J]. EuroIntervention, 2018, 13(14): 1635-1644.
|
| 27 |
Topilsky Y, Grigioni F, Enriquez-Sarano M. Quantitation of mitral regurgitation [J]. Semin Thorac Cardiovasc Surg, 2011, 23(2): 106-114.
|
| 28 |
Bombace S, Meucci MC, Fortuni F, et al. Beyond aortic stenosis: addressing the challenges of multivalvular disease assessment [J]. Diagnostics (Basel), 2023, 13(12): 2102.
|
| 29 |
De Zan G, van der Bilt I, Broekhuizen LN, et al. Non-invasive assessment of multivalvular heart disease: a comprehensive review [J]. Rev Cardiovasc Med, 2024, 25(1): 29.
|
| 30 |
Vanden EF, Bouchard D, El-Hamamsy I, et al. Effect of aortic valve replacement for aortic stenosis on severity of mitral regurgitation [J]. Ann Thorac Surg, 2007, 83(4): 1279-1284.
|
| 31 |
Annabi MS, Clavel MA, Pibarot P. Dobutamine stress echocardiography in low-flow, low-gradient aortic stenosis: flow reserve does not matter anymore [J]. J Am Heart Assoc, 2019, 8(6): e12212.
|
| 32 |
Annabi MS, Touboul E, Dahou A, et al. Dobutamine stress echocardiography for management of low-flow, low-gradient aortic stenosis [J]. J Am Coll Cardiol, 2018, 71(5): 475-485.
|
| 33 |
Pawade T, Sheth T, Guzzetti E, et al. Why and how to measure aortic valve calcification in patients with aortic stenosis [J]. JACC Cardiovasc Imaging, 2019, 12(9): 1835-1848.
|
| 34 |
Šeman M, Stephens AF, Walton A, et al. Impact of concomitant mitral regurgitation on the hemodynamic indicators of aortic stenosis [J]. J Am Heart Assoc, 2023,12(4): e025648.
|
| 35 |
Tamborini G, Piazzese C, Lang RM, et al. Feasibility and accuracy of automated software for transthoracic three-dimensional left ventricular volume and function analysis: comparisons with two-dimensional echocardiography, three-dimensional transthoracic manual method, and cardiac magnetic resonance imaging [J]. J Am Soc Echocardiogr, 2017, 30(11): 1049-1058.
|
| 36 |
Carrillo ML, Tercero FJ, Cruz SD, et al. Septal ablation to treat subaortic dynamic obstruction following transcatheter aortic valve implantation [J]. J Am Coll Cardiol, 2024, 84(4): 411-415.
|
| 37 |
Unger P, Lancellotti P, de Cannière D. The clinical challenge of concomitant aortic and mitral valve stenosis [J]. Acta Cardiol, 2016, 71(1): 3-6.
|
| 38 |
Fischer Q, Himbert D, Bernier M, et al. Impact of moderate to severe mitral stenosis in patients undergoing transcatheter aortic valve replacement [J]. Int J Cardiol, 2019, 286: 36-42.
|
| 39 |
Honey M. Clinical and haemodynamic observations on combined mitral and aortic stenosis [J]. Br Heart J, 1961, 23(5): 545-555.
|
| 40 |
Baumgartner H, Hung J, Bermejo J, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice [J]. J Am Soc Echocardiogr, 2009, 22(1): 1-102.
|
| 41 |
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines [J]. J Am Coll Cardiol, 2021, 77(4): e25-e197.
|
| 42 |
Mantovani F, Fanti D, Tafciu E, et al. When aortic stenosis is not alone: epidemiology, pathophysiology, diagnosis and management in mixed and combined valvular disease [J]. Front Cardiovasc Med, 2021, 8: 744497.
|
| 43 |
Doris MK, Jenkins W, Robson P, et al. Computed tomography aortic valve calcium scoring for the assessment of aortic stenosis progression [J]. Heart, 2020, 106(24): 1906-1913.
|
| 44 |
Bissessor N, Shanahan L, Wee YS, et al. The role of natriuretic peptides in patients with chronic complex (mixed or multiple) heart valve disease [J]. Congest Heart Fail, 2010, 16(2): 50-54.
|
| 45 |
Dumont C, Galli E, Oger E, et al. Pre- and postoperative tricuspid regurgitation in patients with severe symptomatic aortic stenosis: importance of pre-operative tricuspid annulus diameter [J]. Eur Heart J Cardiovasc Imaging, 2018, 19(3): 319-328.
|
| 46 |
Shiran A, Sagie A. Tricuspid regurgitation in mitral valve disease incidence, prognostic implications, mechanism, and management [J]. J Am Coll Cardiol, 2009, 53(5): 401-408.
|
| 47 |
Taramasso M, Vanermen H, Maisano F, et al. The growing clinical importance of secondary tricuspid regurgitation [J]. J Am Coll Cardiol, 2012, 59(8): 703-710.
|
| 48 |
Dahou A, Magne J, Clavel MA, et al. Tricuspid regurgitation is associated with increased risk of mortality in patients with low-flow low-gradient aortic stenosis and reduced ejection fraction: results of the multicenter TOPAS study (True or Pseudo-Severe Aortic Stenosis) [J]. JACC Cardiovasc Interv, 2015, 8(4): 588-596.
|
| 49 |
Vieitez JM, Monteagudo JM, Mahia P, et al. New insights of tricuspid regurgitation: a large-scale prospective cohort study [J]. Eur Heart J Cardiovasc Imaging, 2021, 22(2): 196-202.
|
| 50 |
Cigarroa RG, Lange RA, Williams RH, et al. Underestimation of cardiac output by thermodilution in patients with tricuspid regurgitation [J]. Am J Med, 1989, 86(4): 417-420.
|
| 51 |
Mascherbauer J, Kammerlander AA, Marzluf BA, et al. Prognostic impact of tricuspid regurgitation in patients undergoing aortic valve surgery for aortic stenosis [J]. PLoS One, 2015, 10(8): e136024.
|
| 52 |
Généreux P, Pibarot P, Redfors B, et al. Staging classification of aortic stenosis based on the extent of cardiac damage [J]. Eur Heart J, 2017, 38(45): 3351-3358.
|